{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:12:18Z","timestamp":1790878338279,"version":"4.1.0"},"reference-count":47,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004024","name":"Special Fund for the Construction of High-Level Universities in Guangdong Province","doi-asserted-by":"publisher","award":["88020032"],"award-info":[{"award-number":["88020032"]}],"id":[{"id":"10.13039\/501100004024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Herpes simplex virus type 1 (HSV-1) infections are prevalent illnesses that can cause mucocutaneous ulcerative disease, keratitis, and genital herpes. In patients with compromised immune systems, the infection can lead to serious problems, such as encephalitis. Additionally, neonatal infections can cause brain problems and even death. Current first-line antiviral drugs are nucleoside analog inhibitors that target viral polymerase, and resistant strains have emerged. As a result, new drugs with distinct action modes are needed. Recent research indicates that cyclin-dependent kinases (CDKs) are prospective antiviral targets. Thus, CDK inhibitors may be effective antiviral agents against HSV-1 infection. In this study, we examined a panel of CDK inhibitors that target CDKs in the present study. BMS-265246 (BMS), a CDK 1\/2 inhibitor, was found to effectively limit HSV-1 multiplication in Vero, HepG2, and Hela cells. A mechanism of action study suggested that BMS inhibits the early stages of viral replication when added early in the viral infection. The suppression of multiple steps in viral replication by BMS was revealed when HSV-1 infected cells were treated at different time periods in the viral life cycle. Our results suggest that BMS is a potent anti-HSV-1 agent and unique in that it may interfere with multiple steps in HSV-1 replication.<\/jats:p>","DOI":"10.3390\/v15081642","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T01:56:16Z","timestamp":1690509376000},"page":"1642","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["BMS-265246, a Cyclin-Dependent Kinase Inhibitor, Inhibits the Infection of Herpes Simplex Virus Type 1"],"prefix":"10.3390","volume":"15","author":[{"given":"Lefang","family":"Jiang","sequence":"first","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuogang","family":"Li","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yarou","family":"Gao","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haonan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Cao","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Peng","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4479-1145","authenticated-orcid":false,"given":"Xulin","family":"Chen","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"key":"ref_1","unstructured":"WHO (2023, April 05). Herpes Simplex Virus. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/herpes-simplex-virus."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1079-2104(97)90342-5","article-title":"Reactivation of oral herpes simplex virus: Implications for clinical management of herpes simplex virus recurrence during radiotherapy","volume":"84","author":"Oakley","year":"1997","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0030-4220(85)90085-4","article-title":"Chronic oral herpes simplex virus infection in immunocompromised patients","volume":"59","author":"Cohen","year":"1985","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1023\/A:1026156130656","article-title":"Apoptosis participates to liver damage in HSV-induced fulminant hepatitis","volume":"8","author":"Pelletier","year":"2003","journal-title":"Apoptosis"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Price, N.B., and Wood, K.E. (2021). Distinguishing Features Common to Dual Fatal Herpes Simplex Virus Infections That Occur in Both a Pregnant Woman and Her Newborn Infant. Viruses, 13.","DOI":"10.3390\/v13122542"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.clp.2021.03.003","article-title":"Neonatal Herpes Simplex Virus Disease: Updates and Continued Challenges","volume":"48","author":"Samies","year":"2021","journal-title":"Clin. Perinatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/bmb\/ldt011","article-title":"Recent developments in anti-herpesvirus drugs","volume":"106","author":"Field","year":"2013","journal-title":"Br. Med. Bull."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-405880-4.00001-9","article-title":"Antiviral Agents for Herpes Simplex Virus","volume":"67","author":"Hodge","year":"2013","journal-title":"Adv. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Shiraki, K., Yasumoto, S., Toyama, N., and Fukuda, H. (2021). Amenamevir, a Helicase-Primase Inhibitor, for the Optimal Treatment of Herpes Zoster. Viruses, 13.","DOI":"10.3390\/v13081547"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1386-6532(02)00263-9","article-title":"Herpes simplex virus resistance to antiviral drugs","volume":"26","author":"Morfin","year":"2003","journal-title":"J. Clin. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jcv.2011.06.009","article-title":"Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children","volume":"52","author":"Wang","year":"2011","journal-title":"J. Clin. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1086\/422364","article-title":"Resistance of Herpes Simplex Virus Infections to Nucleoside Analogues in HIV-Infected Patients","volume":"39","author":"Levin","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1368-7646(02)00021-3","article-title":"Resistance of herpesviruses to antiviral drugs: Clinical impacts and molecular mechanisms","volume":"5","author":"Gilbert","year":"2002","journal-title":"Drug Resist. Updat."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/infdis\/jit350","article-title":"Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis","volume":"208","author":"Osterhaus","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1086\/590668","article-title":"Acyclovir-Resistant Corneal HSV-1 Isolates from Patients with Herpetic Keratitis","volume":"198","author":"Duan","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Dogrammatzis, C., Waisner, H., and Kalamvoki, M. (2020). \u201cNon-Essential\u201d Proteins of HSV-1 with Essential Roles In Vivo: A Comprehensive Review. Viruses, 13.","DOI":"10.3390\/v13010017"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Packard, J.E., and Dembowski, J.A. (2021). HSV-1 DNA Replication\u2014Coordinated Regulation by Viral and Cellular Factors. Viruses, 13.","DOI":"10.3390\/v13102015"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2741\/taylor","article-title":"Herpes simplex virus","volume":"7","author":"Taylor","year":"2002","journal-title":"Front. Biosci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.tim.2021.01.014","article-title":"Cyclin-dependent Kinases as Emerging Targets for Developing Novel Antiviral Therapeutics","volume":"29","author":"Felip","year":"2021","journal-title":"Trends Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1128\/JVI.72.7.5626-5637.1998","article-title":"Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription","volume":"72","author":"Schang","year":"1998","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1128\/JVI.74.5.2107-2120.2000","article-title":"Roscovitine, a Specific Inhibitor of Cellular Cyclin-Dependent Kinases, Inhibits Herpes Simplex Virus DNA Synthesis in the Presence of Viral Early Proteins","volume":"74","author":"Schang","year":"2000","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1128\/JVI.73.3.2161-2172.1999","article-title":"Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases","volume":"73","author":"Schang","year":"1999","journal-title":"J. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1081\/NCN-200060314","article-title":"CDK inhibitory nucleoside analogs prevent transcription from viral genomes","volume":"24","author":"Schang","year":"2005","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1172\/JCI73805","article-title":"CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses","volume":"124","author":"Yamamoto","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1128\/JVI.76.15.7724-7735.2002","article-title":"Explant-Induced Reactivation of Herpes Simplex Virus Occurs in Neurons Expressing Nuclear cdk2 and cdk4","volume":"76","author":"Schang","year":"2002","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/viro.1997.8489","article-title":"Inhibition of Cellular Cdk2 Activity Blocks Human Cytomegalovirus Replication","volume":"231","author":"Bresnahan","year":"1997","journal-title":"Virology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jac\/dkv363","article-title":"Inhibition of herpes simplex virus type 1 by the CDK6 inhibitor PD-0332991 (palbociclib) through the control of SAMHD1","volume":"71","author":"Badia","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbapap.2003.11.026","article-title":"Viral and cellular kinases are potential antiviral targets and have a central role in varicella zoster virus pathogenesis","volume":"1697","author":"Moffat","year":"2004","journal-title":"Biochim. Biophys. Acta (BBA) Proteins Proteom."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1681\/ASN.V12122827","article-title":"Suppression of HIV-1 expression by inhibitors of cyclin-dependent kinases promotes differentiation of infected podocytes","volume":"12","author":"Nelson","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-6405-7-7","article-title":"Inhibition of human immunodeficiency virus type-1 by cdk inhibitors","volume":"7","author":"Guendel","year":"2010","journal-title":"AIDS Res. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1097\/QAD.0000000000000399","article-title":"Palbociclib, a selective inhibitor of cyclin-dependent kinase4\/6, blocks HIV-1 reverse transcription through the control of sterile alpha motif and HD domain-containing protein-1 (SAMHD1) activity","volume":"28","author":"Pauls","year":"2014","journal-title":"Aids"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1089\/adt.2015.0003.drrr","article-title":"Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication","volume":"13","author":"Perwitasari","year":"2015","journal-title":"ASSAY Drug Dev. Technol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen","volume":"22","author":"Xu","year":"2016","journal-title":"Nat. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.antiviral.2016.08.008","article-title":"Inhibitory effect of CDK9 inhibitor FIT-039 on hepatitis B virus propagation","volume":"133","author":"Tanaka","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/bph.14918","article-title":"Guanidine modifications enhance the anti-herpes simplex virus activity of (E,E)-4,6-bis(styryl)-pyrimidine derivatives in vitro and in vivo","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/S0960-894X(03)00381-0","article-title":"1H-Pyrazolo[3,4-b]pyridine inhibitors of cyclin-dependent kinases: Highly potent 2,6-Difluorophenacyl analogues","volume":"13","author":"Misra","year":"2003","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1126\/science.2452480","article-title":"Dextran Sulfate Suppression of Viruses in the HIV Family: Inhibition of Virion Binding to CD4+ Cells","volume":"240","author":"Mitsuya","year":"1988","journal-title":"Science"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1185504","DOI":"10.3389\/fmicb.2023.1185504","article-title":"Dextran sulfate from Leuconostoc mesenteroides B512F exerts potent antiviral activity against SARS-CoV-2 in vitro and in vivo","volume":"14","author":"Andreu","year":"2023","journal-title":"Front. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.antiviral.2012.09.012","article-title":"Influenza virus neuraminidase contributes to the dextran sulfate-dependent suppressive replication of some influenza A virus strains","volume":"96","author":"Yamada","year":"2012","journal-title":"Antivir. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1747-1028-5-11","article-title":"An overview of Cdk1-controlled targets and processes","volume":"5","author":"Enserink","year":"2010","journal-title":"Cell Div."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1573406415666190626113900","article-title":"Inhibitors of Cyclin-Dependent Kinase 1\/2 for Anticancer Treatment","volume":"16","author":"Mou","year":"2020","journal-title":"Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.bbapap.2009.10.002","article-title":"Recent developments in cyclin-dependent kinase biochemical and structural studies","volume":"1804","author":"Echalier","year":"2010","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.cub.2003.09.024","article-title":"Cdk2 Knockout Mice Are Viable","volume":"13","author":"Berthet","year":"2003","journal-title":"Curr. Biol."},{"key":"ref_44","first-page":"e148749","article-title":"Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19","volume":"6","author":"Kamle","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00280-018-3726-1","article-title":"6-MOMIPP, a novel brain-penetrant anti-mitotic indolyl-chalcone, inhibits glioblastoma growth and viability","volume":"83","author":"Du","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Wang, R., Yang, J.F., Ho, F., Robertson, E.S., and You, J. (2020). Bromodomain-Containing Protein BRD4 Is Hyperphosphorylated in Mitosis. Cancers, 12.","DOI":"10.3390\/cancers12061637"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"De Meo, S., Dell\u2019oste, V., Molfetta, R., Tassinari, V., Lotti, L.V., Vespa, S., Pignoloni, B., Covino, D.A., Fantuzzi, L., and Bona, R. (2020). SAMHD1 phosphorylation and cytoplasmic relocalization after human cytomegalovirus infection limits its antiviral activity. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008855"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/8\/1642\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:21:10Z","timestamp":1760127670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/8\/1642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["v15081642"],"URL":"https:\/\/doi.org\/10.3390\/v15081642","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,28]]}}}